Skip Navigation

Journal of Tropical Pediatrics 2000 46(2):86-91; doi:10.1093/tropej/46.2.86
© 2000 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Musoke, R.
Right arrow Articles by Revathi, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Musoke, R.
Right arrow Articles by Revathi, G
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Emergence of multidrug-resistant gram-negative organisms in a neonatal unit and the therapeutic implications

RN MusokeA and G RevathiB

Departments of A Paediatrics and B Microbiology, University of Nairobi and Kenyatta National Hospital, Nairobi, Kenya

Multidrug-resistant organisms are increasing worldwide. Over the years we have noted increasing resistance of organisms isolated in our neonatal unit. There is a need therefore to scrutinise the problem so as to be able to plan for the future. Over a 5-month period, 716 infants were admitted of which 192 were screened for sepsis. Overall, 121 (16.7 per cent) had positive blood cultures. The predominant organisms were Gram negative (73.6 per cent of isolates) with Klebsiella species topping the list at 31 per cent. Case fatality for infants infected with Gram negative organisms was 41 per cent. Resistance to gentamicin was 20 per cent chloramphenicol 23.6 per cent, and amoxicillin/ampicillin 66.3 per cent. Of worry is the resistance to ceftazidime 19.1 per cent, and cefuroxime 21.3 per cent, with the figures rising to 27 per cent when more specialized tests are done (disc approximation and potentiation tests). If these drugs cannot be used in 20-27 per cent of cases then the situation is serious. The contributory factors to increased resistance include: non-investigation of infants put on antibiotics (50 per cent of cases); prolonged (73 per cent) and sometimes unjustified (41.7 per cent) use of antibiotics; and non-utilization of investigations when these are done (52 per cent) together with the delay in getting results back in the ward (6 days).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
D. L. Paterson and R. A. Bonomo
Extended-Spectrum {beta}-Lactamases: a Clinical Update
Clin. Microbiol. Rev., October 1, 2005; 18(4): 657 - 686.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P. Bejon, I. Mwangi, C. Ngetsa, S. Mwarumba, J. A. Berkley, B. S. Lowe, K. Maitland, K. Marsh, M. English, and J. A. G. Scott
Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya
J. Antimicrob. Chemother., July 1, 2005; 56(1): 232 - 235.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
T Duke
Neonatal pneumonia in developing countries
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2005; 90(3): F211 - f219.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
S Vergnano, M Sharland, P Kazembe, C Mwansambo, and P T Heath
Neonatal sepsis: an international perspective
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2005; 90(3): F220 - f224.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
D. Kaufman and K. D. Fairchild
Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants
Clin. Microbiol. Rev., July 1, 2004; 17(3): 638 - 680.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
ADA COUNCIL ON SCIENTIFIC AFFAIRS
Combating antibiotic resistance
J Am Dent Assoc, April 1, 2004; 135(4): 484 - 487.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. Toltzis, M. J. Dul, C. Hoyen, A. Salvator, M. Walsh, L. Zetts, and H. Toltzis
Molecular Epidemiology of Antibiotic-Resistant Gram-Negative Bacilli in a Neonatal Intensive Care Unit During a Nonoutbreak Period
Pediatrics, November 1, 2001; 108(5): 1143 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Kariuki, J. E. Corkill, G. Revathi, R. Musoke, and C. A. Hart
Molecular Characterization of a Novel Plasmid-Encoded Cefotaximase (CTX-M-12) Found in Clinical Klebsiella pneumoniae Isolates from Kenya
Antimicrob. Agents Chemother., July 1, 2001; 45(7): 2141 - 2143.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.